Register for email alerts and news feeds:
This journal | BMJ Group
rss
Gut 2006;55:1532-1533; doi:10.1136/gut.2006.103283
Copyright © 2006 BMJ Publishing Group Ltd & British Society of Gastroenterology.

COMMENTARY

Oesophageal cancer

Acid inhibitory medication and risk of gastric and oesophageal cancer

K E L McColl

Correspondence to:
Correspondence to:
Professor K E L McColl
Section of Medicine, Gardiner Institute, Western Infirmary, 44 Church Street, Glasgow G11 6NT, UK; K.E.L.McColl@clinmed.gla.ac.uk


What are the long term effects of acid suppressive medication on the risk of gastric and oesophageal cancer?

Keywords: histamine H2 antagonists; proton pump inhibitors; gastric acid suppression; oesophageal adenocarcinoma; gastric cancer

The first 150 words of the full text of this article appear below.

It is now 30 years since effective antisecretory drugs in the form of H2 receptor antagonists became available for use in clinical practice. Since then the use of medications which elevate intragastric pH has progressively increased and a significant proportion of the population is taking powerful antisecretory medication on a long term basis. In view of the recognised association between hypochlorhydria and gastric cancer,1,2 there has been concern that long term use of acid suppressive medication might increase the risk of this sinister condition. In this issue of Gut, García Rodríguez and colleagues3 report the association between long term antisecretory medication and upper gastrointestinal cancer (see page 1538).

The study used the UK general practitioners research database (GPRD) which is a primary care automated database initiated in the late 1980s and currently including more then 3 million subjects. It contains detailed information on patient demographics, . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK
L A García Rodríguez, J Lagergren, and M Lindblad
Gut 2006 55: 1538-1544. [Abstract] [Full Text] [PDF]

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Cardiology Jobs

Gastroenterology Jobs